As a part of our efforts to bring in various perspectives to the global health discussion in Japan, JCIE often invites distinguished experts to the Executive Committee on Global Health and Human Security to share their insights and engage in discussions with the committee members.
On May 19, ten leaders of the global health organizations that comprise the Access to COVID-19 Tools (ACT) Accelerator, as well as Ambassador Carl Bildt, WHO Special Envoy for ACT-Accelerator, joined the Special Session of the Executive Committee to explain how this unprecedented global health partnership is helping develop and equitably distribute all the critical COVID-19 tools—diagnostics, therapeutics, and vaccines, as well as the health systems connector. The discussion covered the ACT-Accelerator’s achievements over the previous year and its priorities for 2021. The ACT-Accelerator partners expressed what is needed to succeed in turning the tide on the pandemic, and how Japan can position its contributions to the ACT-Accelerator within the country’s global health priorities.
Welcome
Akio Okawara, President and CEO, JCIE
Opening remarks
Hon Keizo Takemi, Member of House of Councillors and WHO Goodwill Ambassador for UHC
Remarks
Hon Carl Bildt, WHO Special Envoy for ACT-Accelerator
Remarks from Government of Japan representative
Keiichi Ono, Director-General for Global Issues, Ministry of Foreign Affairs
Remarks from WHO representative
Takeshi Kasai, Regional Director, WPRO
ACT-Accelerator overview
Bruce Aylward, Senior Advisor to the Director General of WHO and Lead for ACT-Accelerator
Panel discussion
Moderator: Bruce Aylward
Panelists:
Seth Berkley, CEO, Gavi, the Vaccine Alliance
Philippe Duneton, Executive Director, Unitaid
Charlotte Petri Gornitzka, Deputy Executive Director, UNICEF
Richard Hatchett, CEO, Cepi
Emma Hannay, Chief Access Officer, FIND
Muhammad Ali Pate, Director, GFF
Peter Sands, Executive Director, The Global Fund
Mariângela Batista Galvão Simão, Assistant Director-General, Access to Medicines and Health Products
Q&A and discussion
Moderator: Keizo Takemi
Closing remarks
Keizo Takemi
ACT-Accelerator Hub and partner organizations (online)
Carl Bildt, World Health Organization (WHO) Special Envoy for ACT-Accelerator
(alphabetical order)
Bruce Aylward, Senior Advisor to the Director General of WHO; Head for ACT-Accelerator
Seth Berkley, CEO, Gavi, the Vaccine Alliance
Philippe Duneton, Executive Director, Unitaid
Charlotte Petri Gornitzka, Deputy Executive Director, UNICEF
Emma Hannay, Chief Access Officer, Foundation for Innovative New Diagnostics (FIND)
Richard Hatchett, CEO, Cepi
Muhammad Ali Pate, Director, Global Financing Facility
Peter Sands, Executive Director, The Global Fund to Fight AIDS, Tuberculosis and Malaria
Mariângela Batista Galvão Simão, Assistant Director-General, Access to Medicines and Health Products, WHO
Executive Committee Members and other Japanese participants
Chair: Keizo Takemi, Member, House of Councillors (Liberal Democratic Party: LDP); Senior Fellow, Japan Center for International Exchange (JCIE)
Director: Akio Okawara, President and CEO, JCIE
Senior Advisors: Yasuhisa Shiozaki, Member, House of Representatives (LDP)
(alphabetical order)
Kozo Akino, Member, House of Councillors (Komeito) (online)
Toshio Fujimoto, Global Public Affairs Head, Global Corporate Affairs, Takeda Pharmaceutical Company Ltd.; General Manager, Takeda’s Health Innovation Park in Shonan (online)
Motohisa Furukawa, Member, House of Representatives (Democratic Party for the People) (online)
Noriko Furuya, Member, House of Representatives (Komeito)
Haruhiko Hirate, President, Hirate & Associates
Masaki Inaba, Representative, Japan CSO Network on Global Health; Director for Global Health, Africa Japan Forum (online)
Sumie Ishii, Chairperson, JOICFP (Japanese Organization for International Cooperation in Family Planning) (online)
Yasushi Katsuma, Professor, International Studies Program, Graduate School of Asia-Pacific Studies (GSAPS); Head of Global Health Affairs & Governance Group, Institute for Global Health Policy (iGHP), National Center for Global Health
& Medicine (NCGM) (online)
Nobuko Kayashima, Vice President, Japan International Cooperation Agency (JICA) (online)
Kiyoshi Kodera, Chair of the board, WaterAid Japan; Senior Research Associate, Overseas Development Institute (online)
Norihiro Kokudo, President, National Center for Global Health and Medicine
Tatsuya Kondo, President, Medical Excellence JAPAN (MEJ); Honorary Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)
Kiyoshi Kurokawa, Adjunct Professor, National Graduate Institute for Policy Studies (GRIPS); Chairman, Health and Global Policy Institute
Karen Makishima, Member, House of Representatives (LDP) (online)
Kenichi Matsumoto, Chairperson, The Japan Federation of Medical Devices Associations (online)
Asahiko Mihara, Member, House of Representatives (LDP)
Masanori Miyazaki, President, National Institute of Public Health (online)
Nobuyuki Morishima, Vice President and Representative Director, Otsuka Pharmaceutical Co., Ltd. (online)
Yasuhide Nakamura, Professor, School of Nursing and Rehabilitation, Konan Women’s University (online)
Hiroki Nakatani, Visiting Professor, School of Medicine, Keio University (observing)
Keitaro Ono, Member, House of Representatives (LDP) (online)
Keiichi Ono, Director-General for Global Issues, Ministry of Foreign Affairs (online)
Johtaro Seki, President, ITEC (International Total Engineering Corporation) (online)
Yukio Takasu, Special Adviser to the Secretary-General on Human Security, UN (online)
Masaaki Taniai, Member, House of Councillors (Komeito)
Isao Teshirogi, President and CEO, Shionogi & Co. Ltd.
Satoko Itoh, Managing Director and Chief Program Officer, JCIE; Assistant Director, Friends of the Global Fund, Japan (FGFJ)
Masaaki Iuchi, Senior Assistant Minister, Ministry of Health, Labour and Welfare
Teiji Takei, Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare
Representatives of members’ organizations:
(alphabetical order)
Tadaaki Kawamura, Director, Development Policy Division, International Bureau, Ministry of Finance
Hiroshi Minami, Deputy Director-General, Office of Healthcare Policy, Cabinet Secretariat
Akira Miura, Cabinet Counsellor, Office for Pandemic Influenza and New Infectious Diseases Preparedness and Response, Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat
Sayoko Sasaki, Vice President, Chief IR Officer, Stakeholder Communications, Eisai Co., Ltd.
Hideto Takagi, Director for Advanced Medical and Radiological Science, Research Promotion Bureau, Ministry of Education, Culture, Sports, Science and Technology
Shinobu Uzu, Senior Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA)
International & overseas organizations:
(alphabetical order)
Takeshi Kasai, Regional Director for the Western Pacific, World Health Organization (WHO)
Mihoko Kashiwakura, Head of Japan, Bill & Melinda Gates Foundation
Robert Benes, Director, The United Nations Children’s Fund (UNICEF) Tokyo Office
Tetsuo Kondo, Director, UNDP Representation Office in Tokyo (online)
Masato Miyazaki, Special Representative in Japan, The World Bank Group
Mariko Sato, Director, The United Nations Population Fund (UNFPA) Tokyo office
